GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells

Journal of Autoimmunity

Volumn 31, Issue 4, 2008, Pages 377-384

  Seydel, F ^a   Garrigan, E ^a   Stutevoss, B ^a   Belkin, N ^a   Makadia, B ^a   Carter, J ^a   Shi, J D ^a   Davoodi Semiromi, A ^a   McDuffie, M ^b   Litherland, S A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Autoimmunity; Cytokines; Diabetes; Monocyte macrophage; Signal transduction

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; C57BL 6 MOUSE; CELL DIFFERENTIATION; CHROMATIN; CHROMOSOME 11; CONTROLLED STUDY; CSF2 GENE; CYTOKINE PRODUCTION; DNA POLYMORPHISM; EPIGENETICS; FEEDBACK SYSTEM; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; IMMUNOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING;

ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; BONE MARROW CELLS; CELLS, CULTURED; CHROMATIN; EPIGENESIS, GENETIC; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; MONOCYTES; MYELOID CELLS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEQUENCE ALIGNMENT; STAT5 TRANSCRIPTION FACTOR;

EID: 56549126625     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.08.010     Document Type: Article

References (34)

1. Hashimoto S., Komuro I., Yamada M., and Akagawa K.S. IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages. J Immunol 167 (2001) 3619-3625
2. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol 23 8 (2002) 403-408
3. Piazza F., Vlens J., Lagasse E., and Schindler C. Myeloid differentiation of FdCP1 cells is dependent on Stat5 processing. Blood 96 4 (2000) 1358-1365
4. Liu R., Itoh T., Arai K., and Watanabe S. Two distinct signaling pathways downstream of Janus kinase 2 play redundant roles for anti-apoptotic activity of granulocyte-macrophage colony-stimulating factor. Mol Biol Cell 10 (1999) 3959-3970
5. Kieslinger M., Woldman I., Moriggl R., Hofmann J., Marine J.-C., Ihle J.N., et al. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev 14 (1999) 232-244
6. Yamaoka K., Otsuka T., Niiro H., Arinobu Y., Nihho Y., Hamasaki N., et al. Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes. J Immunol 160 (1998) 838-845
7. Rosen R.L., Winestock K.D., Chen G., Liu X., Henninghausen L., and Finbloom D.S. Granulocyte-macrophage colony-stimulating factor preferentially activates the 94 kD STAT5A and an 80 kD STAT5A isoform in human peripheral blood monocytes. Blood 88 4 (1996) 1207-1214
8. Ito K., Barnes P.J., and Adcock I.M. Glucocortoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20 18 (2000) 6891-6903
9. Chen X., Wang J., Woltring D., Gerondakis S., and Shannon M.F. Histone dynamics on the interleukin-2 gene in response to T-cell activation. Mol Cell Biol 25 8 (2005) 3209-3219
10. Foegh M.L. Immune regulation by eicosanoids. Transplant Proc 20 6 (1988) 1151-1161
11. Volk H.D., Reinker P., Krausch D., Zuckermann H., Asadullah K., Muller J.M., et al. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22 Suppl. 4 (1996) S474-S481
12. Litherland S.A., Xie T.X., Li Y., Grebe K.M., Reddy S., Moldawer L.L., et al. IL10 resistant PGS2 expression in at-risk/type 1 diabetic human monocytes. J Autoimmun 22 3 (2004) 227-233
13. Litherland S.A., Xie T.X., Grebe K.M., Davoodi-Semiromi A., Elf J., Belkin N.S., et al. Signal transduction activator of transcription 5 (STAT5) proteins are dysfunctional in autoimmune monocytes & macrophages. J Autoimmun 24 (2005) 297-310
14. Litherland S.A., Grebe K.M., Belkin N.S., Paek E., Elf J., Atkinson M., et al. Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and GM-CSF overproduction. J Immunol 175 7 (2005) 4561-4565
15. Nakajima H., Brindle P.K., Handa M., and Ihle J.N. Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. EMBO J 20 23 (2001) 6836-6844
16. Pfitzner E., Jahne R., Wissler M., Stoecklin E., and Groner B. P300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the glucocorticoid response. Mol Endocrinol 12 (1998) 1582-1593
17. Chung C.P., Oeser A., Solus J., Avalos I., Gebretsadik T., Shintani A., et al. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus. J Rheumatol 34 (2007) 1-6
18. Asanuma Y., Chung C.P., Oeser A., Shintani A., Stanley R., Raggi P., et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol 33 (2006) 539-545
19. Wicker LS, Clark J, Fraser HI, Garner VES, Gonzalez-Munoz A, Healy B, et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 25: 29-33.
20. Serreze D.V., Gaskins H.R., and Leiter E.H. Defects in the differentiation and function of antigen presenting cells in the NOD/Lt mice. J Immunol 150 (1993) 2534-2543
21. Ding D., Mehta H., McCune W.J., and Kaplan M.J. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 177 (2006) 5878-5889
22. Skarsvik S., Tiittanen M., Lindstrom A., Casas R., Luvigsson J., and Vaarala O. Poor in vitro maturation and pro-inflammatory cytokine responses of dendritic cells in children at genetic risk of type 1 diabetes. Scand J Immunol 60 (2004) 647-652
23. Abou-Raya A., and Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5 5 (2006) 331
24. Ilaria Jr. R.L., Hawley R.G., and van Etten R.A. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93 12 (1999) 4154-4166
25. Chen H.E., Chang S., Trub T., and Neel B.G. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 16 77 (1996) 3685-3697
26. McDuffie M. Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouse. Clin Immunol 96 2 (2000) 119-130
27. Smale S.T. The establishment and maintenance of lymphocyte identity through gene silencing. Nature Immunol 4 7 (2003) 607-615
28. Nelson J.D., Denisenko O., Sova P., and Bomsztyk K. Fast chromatin immunoprecipitation assay. Nucl Acids Res 34 1 (2006) e2-e7
29. Schindler C., and Darnell Jr. J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64 (1995) 621-651
30. Ehret G.B., Reichenbach R., Schindler U., Horvath C.M., Fritz S., Nabholz M., et al. DNA binding specificity of different STAT proteins. J Biol Chem 276 9 (2001) 6675-6688
31. Soldaini E., John S., Moro S., Bollenbacher J., Schindler U., and Leonard W.J. DNA binding site selection of dimeric and tetrameric STAT5 proteins reveals a large repertoire of divergent tetrameric STAT5α binding sites. Mol Cell Biol 20 1 (2000) 389-401
32. Schuster B., Hendry L., Byers H., Lynham S.F., Ward M.A., and John S. Purification and identification of the STAT5 protease in myeloid cells. Biochem J 404 (2007) 81-87
33. Ramos H.L., O'Shea J.J., and Watford W.T. STAT5 isoforms: controversies and clarifications. Biochem J 404 (2007) e1-e2
34. Neculai D., Neculai A.M., Verrier S., Straub K., Klump K., Pfitzner E., et al. Structure of the unphosphorylated STAT5a dimer. J Biol Chem 280 49 (2005) 40782-40787